Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Emerald BioStructures, UCB Extend Collaboration

October 27, 2011 12:16 pm | News | Comments

Emerald BioStructures announced a three-year extension of its ongoing collaboration with UCB.


Almac Invests $1.4 Million in Laboratory

October 27, 2011 12:12 pm | News | Comments

Almac has established a mass spectrometry laboratory in their European Headquarters, Craigavon, United Kingdom.


Digital Thermometer

October 27, 2011 8:15 am | Product Releases | Comments

Control Company’s Traceable digital hygrometer/thermometer/dew point instrument provides a response time of under 10 seconds with a resolution of 0.01% RH, 0.01°F/°C, and 0.01° dew point °F/°C.


Water Purification Unit

October 27, 2011 8:10 am | Product Releases | Comments

The arium pro from Sartorius Stedim Biotech provides ultrapure water for analytical applications like atomic absorption, ion exchange chromatography and inductively coupled plasma mass spectrometry.


Boehringer Buys Hamilton System for Research Center

October 27, 2011 7:53 am | News | Comments

Hamilton Storage Technologies and Robotics have delivered and successfully installed an integrated compound management system at Boehringer Ingelheim's Research and Development Centre.


Activartis in Phase 2 Trial of Cancer Therapy

October 27, 2011 7:45 am | News | Comments

Activartis GmbH is developing a cancer immunotherapy concept which is currently in Phase 2 clinical trials. The Activartis platform focuses on dendritic cells, the key regulatory elements of the immune system.


Victoza Boosts Novo Nordisk Profits

October 27, 2011 7:39 am | News | Comments

Danish pharmaceutical company Novo Nordisk A/S says its net profit grew by 17% in the third quarter, chiefly spurred by strong sales of its new diabetes drugs.


EU Expands Prevnar Approval

October 27, 2011 7:35 am | News | Comments

Pfizer Inc.'s blockbuster vaccine against dangerous bacterial infections has been approved in Europe for use in adults age 50 and older, the drugmaker announced.


AstraZeneca Profits Drop 2%

October 27, 2011 7:32 am | News | Comments

Drug maker AstraZeneca says underlying profit was down 2% in the third quarter but net profit more than doubled because of the sale of a subsidiary.


Bayer Earnings More Than Double

October 27, 2011 7:30 am | News | Comments

Bayer AG says its earnings more than doubled in the third quarter compared with a year-earlier figure that was weighed down by one-time charges.


Bristol-Myers 3Q Profit Rises 2%

October 27, 2011 7:27 am | by Linda A. Johnson | News | Comments

Drugmaker Bristol-Myers Squibb Co. reported a 2% increase in its third-quarter profit, as price increases and higher sales of several key medicines were mostly offset by higher taxes and increased research and marketing costs.


MRI Software System

October 26, 2011 12:44 pm | Product Releases | Comments

Aspect Imaging’s Certainti software offers a push button approach for preclinical research applications on its M2 MRI system.

Phase 1 Trial Completion of AP301

October 26, 2011 12:38 pm | News | Comments

Apeptico announced completion of a Phase 1 clinical trial for its pulmonary sodium ion channel activator AP301.


Inhibitor Reduces Lung Function Loss

October 26, 2011 12:34 pm | News | Comments

Boehringer Ingelheim’s investigational tyrosine kinase inhibitor BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis.


FDA Flexible in Reviewing Rare Disease Therapies

October 26, 2011 12:31 pm | News | Comments

The National Organization for Rare Disorders released a report documenting flexibility in the Food and Drug Administration review of potential treatments for patients with rare diseases.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.